Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQJX5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,798
Award facts
- Contract value 100% obligated
- $43,798.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,798.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on January 30, 2026, with an ultimate completion date of February 23, 2026, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain since its registration in the System for Award Management in 2001. The company's PPV-G GEN V prime contract, awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the DLA to issue delivery orders for a comprehensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This Mirena delivery order represents one of numerous orders issued to the contractor, reflecting its demonstrated capability to fulfill the specialized pharmaceutical requirements of military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQJX5?
SPE2DR26FQJX5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FQJX5 worth?
The government has obligated $43,798 on SPE2DR26FQJX5.
Is contract SPE2DR26FQJX5 an order under another contract?
Yes. SPE2DR26FQJX5 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJX5 competed?
The extent of competition for SPE2DR26FQJX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award